Lambert-Swainston C, Samlowski W, Reynolds B, Hedayat A
Front Oncol. 2025; 15:1500785.
PMID: 39949752
PMC: 11821627.
DOI: 10.3389/fonc.2025.1500785.
Brambullo T, De Lazzari A, Franchi A, Trevisson E, Garau M, Scarmozzino F
J Clin Med. 2024; 13(8).
PMID: 38673513
PMC: 11050603.
DOI: 10.3390/jcm13082240.
Scurtu L, Petrica M, Scurtu F, Simionescu A, Popescu M, Simionescu O
Front Med (Lausanne). 2024; 11:1381492.
PMID: 38549869
PMC: 10977600.
DOI: 10.3389/fmed.2024.1381492.
Rodriguez-Acevedo A, Antonsson A, Liyanage U, Hughes M, Gordon S, van der Pols J
BMC Cancer. 2022; 22(1):490.
PMID: 35505292
PMC: 9063108.
DOI: 10.1186/s12885-022-09565-6.
Nawrocka P, Galka-Marciniak P, Urbanek-Trzeciak M, M-Thirusenthilarasan I, Szostak N, Philips A
Front Oncol. 2021; 11:752579.
PMID: 34900699
PMC: 8656283.
DOI: 10.3389/fonc.2021.752579.
Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series.
Weissman J, Samlowski W, Meoz R
Oncologist. 2021; 26(12):e2247-e2253.
PMID: 34472658
PMC: 8649029.
DOI: 10.1002/onco.13959.
Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer.
Dasari S, Yedjou C, Brodell R, Cruse A, Tchounwou P
Nanotechnol Rev. 2021; 9(1):1500-1521.
PMID: 33912377
PMC: 8078871.
DOI: 10.1515/ntrev-2020-0117.
Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.
Fathi F, Zamani B, Piroozmand A, Mozafarpoor S, Seyedhashemi E, Arefnezhad R
Mol Biol Rep. 2021; 48(3):2047-2052.
PMID: 33389528
DOI: 10.1007/s11033-020-06115-w.
STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.
Slawinska M, Zablotna M, Glen J, Lakomy J, Nowicki R, Sobjanek M
Arch Dermatol Res. 2019; 311(9):697-704.
PMID: 31342143
PMC: 6787107.
DOI: 10.1007/s00403-019-01952-7.
Exploration of potential key pathways and genes in multiple ocular cancers through bioinformatics analysis.
Wan Q, Tang J
Graefes Arch Clin Exp Ophthalmol. 2019; 257(10):2329-2341.
PMID: 31309275
DOI: 10.1007/s00417-019-04410-2.
Taxifolin Activates the Nrf2 Anti-Oxidative Stress Pathway in Mouse Skin Epidermal JB6 P+ Cells through Epigenetic Modifications.
Kuang H, Tang Z, Zhang C, Wang Z, Li W, Yang C
Int J Mol Sci. 2017; 18(7).
PMID: 28714938
PMC: 5536034.
DOI: 10.3390/ijms18071546.
Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.
Lin Y, Chahal H, Wu W, Cho H, Ransohoff K, Song F
Int J Cancer. 2017; 141(5):952-957.
PMID: 28510302
PMC: 5842918.
DOI: 10.1002/ijc.30786.
Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.
Karimi K, Lindgren T, Koch C, Brodell R
Rev Endocr Metab Disord. 2016; 17(3):389-403.
PMID: 27832418
DOI: 10.1007/s11154-016-9393-9.
The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma.
Sobhani M, Taheri A, Jafarian A, Hashemy S
J Cancer Res Clin Oncol. 2016; 142(11):2303-7.
PMID: 27601162
DOI: 10.1007/s00432-016-2242-0.
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.
Bonilla X, Parmentier L, King B, Bezrukov F, Kaya G, Zoete V
Nat Genet. 2016; 48(4):398-406.
PMID: 26950094
DOI: 10.1038/ng.3525.
Clinical correlation of extensive-stage small-cell lung cancer genomics.
Dowlati A, Lipka M, McColl K, Dabir S, Behtaj M, Kresak A
Ann Oncol. 2016; 27(4):642-7.
PMID: 26802149
PMC: 4803453.
DOI: 10.1093/annonc/mdw005.
Toward precision medicine in glioblastoma: the promise and the challenges.
Prados M, Byron S, Tran N, Phillips J, Molinaro A, Ligon K
Neuro Oncol. 2015; 17(8):1051-63.
PMID: 25934816
PMC: 4490873.
DOI: 10.1093/neuonc/nov031.
Molecular and genetic aspects of odontogenic lesions.
Bilodeau E, Prasad J, Alawi F, Seethala R
Head Neck Pathol. 2014; 8(4):400-10.
PMID: 25409852
PMC: 4245404.
DOI: 10.1007/s12105-014-0588-7.
Drug delivery nanoparticles in skin cancers.
Dianzani C, Zara G, Maina G, Pettazzoni P, Pizzimenti S, Rossi F
Biomed Res Int. 2014; 2014:895986.
PMID: 25101298
PMC: 4102061.
DOI: 10.1155/2014/895986.
Identification of recurrent SMO and BRAF mutations in ameloblastomas.
Sweeney R, McClary A, Myers B, Biscocho J, Neahring L, Kwei K
Nat Genet. 2014; 46(7):722-5.
PMID: 24859340
PMC: 4418232.
DOI: 10.1038/ng.2986.